Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent
ORPHA:102379Acute myeloid leukemia and myelodysplastic syndromes related to radiation
ORPHA:164726Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor
ORPHA:102381Alpha-thalassemia-myelodysplastic syndrome
ORPHA:231401Autosomal recessive spastic paraplegia type 21
ORPHA:101001Familial atypical multiple mole melanoma syndrome
ORPHA:404560Mammary-digital-nail syndrome
ORPHA:238744Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome
ORPHA:363649Middle aortic syndrome
ORPHA:1456Myelodysplastic neoplasm with increased blasts
ORPHA:86839Myelodysplastic neoplasm with increased blasts type 1
ORPHA:100019Myelodysplastic neoplasm with increased blasts type 2
ORPHA:100020Myelodysplastic neoplasm with low blasts
ORPHA:98826Myelodysplastic syndrome
ORPHA:52688Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality
ORPHA:86841Myelodysplastic/myeloproliferative disease
ORPHA:98275Myotonic syndrome
ORPHA:206970OBSOLETE: Chondrodysplastic malformation syndrome
ORPHA:139015Spondylodysplastic Ehlers-Danlos syndrome
ORPHA:536471Therapy related acute myeloid leukemia and myelodysplastic syndrome
ORPHA:86846Unclassified myelodysplastic syndrome
ORPHA:98827Unclassified myelodysplastic/myeloproliferative disease
ORPHA:98825